Merz Pharmaceuticals, LLC
Raleigh, NC Doing business as Merz Pharmaceutical LLC
- UEI
- UMD1NK9KU143
- CAGE
- 71FU4
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 6601 Six Forks Rd #430, Raleigh, NC 27615, USA
- Website
- merzusa.com
- Founded
- 1953
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Consumer Discretionary
- Consumer Durables & Apparel
- Consumer Goods
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Levodopa | Veterans Integrated Service Network 15 | $236,612 | |
| Levodopa | Veterans Integrated Service Network 15 | $709,836 | |
| Levodopa 42MG inhl cap 60 | Veterans Integrated Service Network 15 | $143,561 | |
| Levodopa NDC 10144-0342-60 | Veterans Integrated Service Network 15 | $653,990 | |
| Merz prolaryn GEL for tamc, hawaii. | Medical Command | $15,000 |
About Merz Pharmaceuticals, LLC
Merz Pharmaceuticals, LLC, a foreign-owned pharmaceutical company headquartered in Raleigh, North Carolina, supplies specialized neurological and metabolic pharmaceutical products to the federal government as a prime contractor under the GSA Federal Supply Schedule 61-IB (Pharmaceuticals and Drugs), with no subcontract footprint.
Merz competes full-and-open across all seven recent awards with no set-aside designation. The company's federal capability portfolio centers on branded pharmaceutical supply: Levodopa (for Parkinson's disease and related neurological conditions), Ampyra (dalfampridine, for multiple sclerosis mobility enhancement), and Inbrijia (tirzepatide, for weight management and glycemic control). Recent delivery order work includes a $709,836 supply of Levodopa awarded by Veterans Integrated Service Network 12 (VISN 12) on March 9, 2026; a $653,990 Levodopa delivery order from VISN 12 awarded September 25, 2024; and a $143,561 Levodopa inhalation capsule delivery order from VISN 12 awarded September 11, 2025.
Customer concentration is acute. VISN 12 accounts for five of seven awards and $97.3 million of the $109.3 million combined potential value. The National Acquisition Center (a civilian federal agency within the VA) holds a single-award Blanket Purchase Agreement with a $12.1 million ceiling through March 12, 2027, for Ampyra and Inbrijia supply; this BPA was awarded March 13, 2025, and is currently in its first option year. The Defense Health Agency represents one award valued at $15 thousand. Merz holds four task orders under the GSA Pharmaceuticals and Drugs Federal Supply Schedule, collectively valued at $13.6 million. The company has been registered in SAM since October 2012.
Of the $109.3 million combined potential value, only $1.5 million (1%) has been obligated to date, reflecting the indefinite-delivery structure of GSA schedule work and the BPA. Recent activity shows awards in 2025 and 2026; no delivery orders have been issued under the Ampyra/Inbrijia BPA since its March 2025 award.
Contract vehicles
Quick answers
What is Merz Pharmaceuticals, LLC's UEI?
Merz Pharmaceuticals, LLC's Unique Entity ID (UEI) in SAM.gov is UMD1NK9KU143.
What is Merz Pharmaceuticals, LLC's CAGE code?
Merz Pharmaceuticals, LLC's CAGE code is 71FU4.
What is Merz Pharmaceuticals, LLC's primary NAICS code?
Merz Pharmaceuticals, LLC's primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Merz Pharmaceuticals, LLC located?
Merz Pharmaceuticals, LLC's physical address in SAM.gov is 6601 Six Forks Rd #430, Raleigh, NC 27615, USA.
Is Merz Pharmaceuticals, LLC registered in SAM.gov?
Yes. Merz Pharmaceuticals, LLC's SAM.gov registration is active through June 18, 2027.
Which contract vehicles does Merz Pharmaceuticals, LLC hold?
Merz Pharmaceuticals, LLC holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Merz Pharmaceuticals, LLC's most recent federal award?
Merz Pharmaceuticals, LLC's most recent federal contract award is Levodopa (36C77026N0048), from Veterans Integrated Service Network 15, on September 8, 2026.
On GovTribe
See Merz Pharmaceuticals, LLC's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors